Home › Calculator › IDNA Dividend Calculator 2026
IDNA DRIP Calculator & Dividend Yield 2026
0.69% YieldFinancial ServicesiShares Genomics Immunology and Healthcare ETF · AMEX
Price: $40.95 · Annual div: $0.2809/share · Frequency: semi-annual · Payout ratio: N/A · Ex-div: 2026-06-15
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
IDNA Dividend Yield
IDNA (iShares Genomics Immunology and Healthcare ETF) has a dividend yield of 0.69%, based on an annual dividend of $0.2809 per share and a price of $40.95. Over the last 12 months it paid $0.2809 per share — a trailing yield of 0.69%. Dividends are paid semi-annual.
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When IDNA pays your bills
Year your monthly dividend income covers each expense (based on current settings)
IDNA Dividend History — Last 13 Payments
| Ex-Dividend Date | Payment Date | Amount / Share | TTM Yield | Stock Price |
|---|---|---|---|---|
| 2026-06-15Latest | 2026-06-18 | $0.1254 | 1.48% | $29.32 |
| 2025-12-16 | 2025-12-19 | $0.1555 | 1.57% | $26.76 |
| 2025-06-16 | 2025-06-20 | $0.1529 | 1.29% | $20.50 |
| 2024-12-17 | 2024-12-20 | $0.1110 | 1.59% | $24.61 |
| 2024-06-11 | 2024-06-17 | $0.1114 | 1.17% | $24.09 |
| 2023-12-20 | 2023-12-27 | $0.1693 | 1.14% | $21.10 |
| 2023-06-07 | 2023-06-13 | $0.0708 | 0.86% | $24.08 |
| 2022-06-09 | 2022-06-15 | $0.1359 | 1.58% | $28.11 |
| 2021-12-13 | 2021-12-17 | $0.2564 | 0.75% | $45.78 |
| 2021-06-10 | 2021-06-16 | $0.0521 | 0.37% | $46.54 |
| 2020-12-14 | 2020-12-18 | $0.0362 | — | — |
| 2020-06-15 | 2020-06-19 | $0.0837 | — | — |
| 2019-12-16 | 2019-12-20 | $0.2402 | — | — |
About iShares Genomics Immunology and Healthcare ETF (IDNA) — Dividend Analysis 2026
The iShares Genomics Immunology and Healthcare ETF (IDNA) is designed to mirror the investment performance of a specific index. This index comprises companies operating in both mature and emerging global markets. These businesses are strategically chosen for their potential to capitalize on sustained innovation and expansion within the crucial fields of genomics, immunology, and bioengineering.
Similar dividend stocks to IDNA
Forward dividend yield from the latest data · open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full IDNA DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open IDNA position with:
🌍 IDNA Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold IDNA.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 0.69% | -2.11% | $69 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 0.59% | -2.21% | $59 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 0.55% | -2.25% | $55 / yr |
| 🇬🇧 UK ISA | 0% | 0.69% | -2.11% | $69 / yr |
| 🇬🇧 UK Taxable | 8.75% | 0.63% | -2.17% | $63 / yr |
| 🇨🇦 TFSA | 0% | 0.69% | -2.11% | $69 / yr |
| 🇨🇦 CA Taxable | 25% | 0.52% | -2.28% | $52 / yr |
| 🇦🇺 Super (pension) | 15% | 0.59% | -2.21% | $59 / yr |
| 🇦🇺 AU Taxable | 30% | 0.48% | -2.32% | $48 / yr |
| 🇩🇪 DE Taxable | 26.375% | 0.51% | -2.29% | $51 / yr |
| 🇫🇷 FR Taxable | 30% | 0.48% | -2.32% | $48 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 IDNA Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $0.28/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 IDNA Dividend Payment Schedule
IDNA pays quarterly — 4 times per year. Ex-div: 2026-06-15.
📊 IDNA vs Financial Services Benchmarks
How IDNA compares to typical Financial Services averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for IDNA sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ IDNA Insider Activity
No recent SEC filings reported in the last 90 days.Peer Group
Similar companies in the same sectorCompare IDNA with peers: IDNA vs DALI · IDNA vs DEW · IDNA vs ECOW
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the IDNA dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
iShares Genomics Immunology and Healthcare ETF (IDNA) is currently trading at $40.95, 6% below its 52-week high. The current dividend yield is 0.69% based on an annual payout of $0.2809 per share.
IDNA (iShares Genomics Immunology and Healthcare ETF) — 0.69% Dividend Yield Analysis
iShares Genomics Immunology and Healthcare ETF (IDNA) is a financial services stock currently trading at $40.95 with a dividend yield of 0.69%. It pays an annual dividend of $0.2809 per share. Over the past 5 years, IDNA has grown its dividend at a compound annual rate of 26.0%.
- Dividend payments are not guaranteed and can be reduced or suspended at any time.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest IDNA News
LiveNews aggregated from public sources via Finnhub & RSS. For informational purposes only.
How investors use the IDNA dividend calculator
Illustrative examples of common use cases, written by the DividendFlow team — not customer reviews.